Luke Freeman-Mills

发表

Five endometrial cancer risk loci identified through genome-wide association analysis

Hui Zhao, Mark McEvoy, Julian Peto, 2016, Nature Genetics.

Germline determinants of colorectal cancer risk and outcome

Luke Freeman-Mills, 2017 .

Nucleotide synthesis is regulated by cytoophidium formation during neurodevelopment and adaptive metabolism

Gabriel N. Aughey, Yichi Xu, Stuart J Grice, 2014, Biology Open.

University of Birmingham Expression of Idh1(R132H) in the Murine Subventricular Zone Stem Cell Niche Recapitulates Features of Early Gliomagenesis

M. Tomková, H. Lockstone, P. Ratcliffe, 2022 .

EXABS-156-CML Beyond TKI Therapy in CML.

M. Copland, Luke Freeman-Mills, 2022, Clinical lymphoma, myeloma & leukemia.

A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMS

A. Pagnamenta, D. Kerr, A. González-Neira, 2014, Gut.

COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study

D. Kerr, T. Powles, C. Várnai, 2020, The Lancet.

Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study.

E. Frangou, Arnoud Boot, D. Kerr, 2016, The lancet. Gastroenterology & hepatology.

Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition

P. Pollock, J. Adam, T. Bosse, 2016, Oncoimmunology.

Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside of the crypt base stem cell niche

M. Bansal, R. Poulsom, I. Tomlinson, 2014, Nature Medicine.

Expression of Idh1R132H in the Murine Subventricular Zone Stem Cell Niche Recapitulates Features of Early Gliomagenesis

I. Tomlinson, M. Tomková, H. Lockstone, 2016, Cancer cell.

POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer

P. Klenerman, I. Tomlinson, T. Bosse, 2015, Clinical Cancer Research.

Immune checkpoint blockade: releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome?

G. Middleton, Luke Freeman-Mills, A. Olsson-Brown, 2020, British Journal of Cancer.

A Crispr Knockout Screen Identifies Foxf1 as a Suppressor of Colorectal Cancer Metastasis that Acts through Reduced mTOR Signalling

Andrew R. Bassett, I. Tomlinson, R. Arnold, 2019, bioRxiv.

POLE proofreading mutations elicit an anti-tumor immune response in endometrial cancer Running title: POLE mutations and immune response in endometrial cancer Authors:

Marchi, Emanuele, P. Klenerman, 2015 .

A Polymorphic Enhancer near GREM1 Influences Bowel Cancer Risk through Differential CDX2 and TCF7L2 Binding

H. Stunnenberg, N. Hubner, I. Tomlinson, 2014, Cell reports.